AAPL 193.32 +0.46 (+0.24%)MSFT 133.04 +0.1 (+0.08%)FB 181.4 +1.03 (+0.57%)ZNGA 6.2 +0.08 (+1.23%)NVDA 144.91 +0.48 (+0.33%)WBA 52.67 +0.01 (+0.02%)GOOG 1088.38 +1.34 (+0.12%)PIH 5.73 0 (0.00%)
AAPL 193.32 +0.46 (+0.24%)MSFT 133.04 +0.1 (+0.08%)FB 181.4 +1.03 (+0.57%)ZNGA 6.2 +0.08 (+1.23%)NVDA 144.91 +0.48 (+0.33%)WBA 52.67 +0.01 (+0.02%)GOOG 1088.38 +1.34 (+0.12%)PIH 5.73 0 (0.00%)

Balance Sheet ADMS Quote Adamas Phar

All | Income Statement | Balance Sheet | Cash Flow | Retained Earnings | PPE Schedule | Intangible and Goodwill Schedule
Year 20142015201620172018
CashAndCashEqui 61 33 24 91 57
ShortTermInvest 61 74 90 82 154
Cash 122 107 114 0 0
AccountReceivab 1 1 1 0 0
Inventories 0 0 0 0 0
DeferredIncomeT 0 0 0 0 0
OtherCurrentAss 0 4 1 1 2
TotalCurrentAss 124 113 117 179 228
PPE 1 3 4 6 6
AccumulatedDepr 0 -1 -1 -3 -2
NetPPE 1 2 3 3 4
EquityAndOtherI 36 13 22 3 0
Goodwill 0 0 0 0 0
IntangibleAsset 0 0 0 0 0
OtherLTAssets 0 0 0 1 3
TotalNonCurrent 38 16 25 7 6
TotalAssets 161 129 142 186 235
ShortTermDebt 0 0 0 0 2
AccountsPayable 4 3 4 0 0
TaxesPayable 5 0 0 0 0
AccruedLiabilit 2 5 2 0 0
DeferredRevenue 0 0 0 0 0
OtherCurrentLia 2 4 4 6 8
TotalCurrentLia 13 12 10 17 24
Debt 0 0 0 0 0
DeferredTaxesLi 0 0 0 0 0
DeferredRevenue 0 0 0 0 0
OtherLTLiabilit 2 1 1 1 3
TotalNonCurrent 2 1 1 103 121
TotalLiabilitie 14 13 10 120 145
CommonStock 0 0 0 0 0
AdditionalPaidI 158 178 255 278 433
RetainedEarning -10 -62 -122 -212 -343
AccumulatedOthe 0 0 0 0 0
TotalStockholde 147 116 132 66 90
TotalLiabilitie 161 129 142 186 235
Adamas Pharmaceuticals Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Adamas Pharmaceuticals Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.